申请人:GENENTECH, INC.
公开号:EP0035454A2
公开(公告)日:1981-09-09
The present invention concerns desacetylthymosin alpha 1, an immune restorative polypeptide hormone. This polypeptide is synthesized in E. coli using recombinant DNA cloning techniques. Based on the known amino acid sequence, a gene coding for thymosin alpha 1 was designed and enzymatically assembled from chemically synthesized oligodeoxyribonucleotide fragments. The gene was ligated into plasmid pBR322, placed under lac operon control, and thymosin alpha 1 expressed as part of a β-galactosidase chimeric protein. Cyanogen bromide cleavage of this protein gave a mixture of polypeptides among which thymosin alpha 1 was detected by radioimmunoassay. The E. coli product is identical to thymosin alpha 1 isolated from calf thymus in amino acid sequence and exhibits similar activity in a radioimmunoassay.
The compound is hence a candidate for administration in effective immunopotentiating dosage in the treatment of immuno-depressed and immuno-suppressed conditions.
本发明涉及一种免疫恢复性多肽激素--去乙酰胸腺肽α1。这种多肽是利用重组 DNA 克隆技术在大肠杆菌中合成的。根据已知的氨基酸序列,设计了胸腺肽α1 的编码基因,并用化学合成的寡脱氧核苷酸片段进行酶切组装。将该基因连接到质粒 pBR322 中,置于 lac 操作子控制下,胸腺肽α1 作为 β-半乳糖苷酶嵌合蛋白的一部分进行表达。该蛋白经溴化氰裂解后产生一种多肽混合物,其中胸腺肽α1可通过放射免疫法检测到。大肠杆菌产物与从小牛胸腺中分离出来的胸腺肽α1在氨基酸序列上完全相同,在放射免疫测定中也表现出相似的活性。
因此,该化合物可用于治疗免疫抑制和免疫抑制病症的有效免疫增强剂量。